Allogeneic Stem Cell Transplantation With Adoptive Immunotherapy in Epstein-Barr Virus Positive Recurrent/Refractory Hodgkins Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01636388
Recruitment Status : Terminated (funding ended)
First Posted : July 10, 2012
Last Update Posted : December 22, 2017
Children's Research Institute
Baylor College of Medicine
M.D. Anderson Cancer Center
City of Hope Medical Center
Johns Hopkins University
Ohio State University
University of Utah
University of Michigan
Information provided by (Responsible Party):
Mitchell Cairo, New York Medical College

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : June 2017
  Actual Study Completion Date : December 2017